AVEO Oncology, an LG Chem company, (AVEO) announced today that the first patient has been successfully dosed in a Phase 1b/2 clinical trial evaluating ficlatuzumab in combination with azacitidine and ...
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...
Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...